IRS Issues Final Rule Implementing Medical Device Excise Tax

The Internal Revenue Service released a

implementing a Patient Protection and Affordable Care Act provision that imposes on certain medical devices made after 2012 an excise tax equal to 2.3% of their sales price. In submitted on the proposed rule AHRMM, the American Hospital Association and others urged the IRS to explicitly prohibit device companies from passing the tax on to customers, and to clarify that hospitals and other healthcare providers who package and sterilize devices for use in surgery kits should not be treated as device manufacturers or importers under the rule. The final rule does not address AHRMM’s recommendation that manufacturers certify that the tax has not been passed on to customers, but provides that current rules apply in determining the sales price of items. Also, of importance, the final rule states that a kit produced by a hospital or medical institution for its own use would not be a taxable medical device.

Related Resources

Advisory
New Guidance on Humidity Levels in the Operating Room
Magazine & Journal Articles
AHRMM's Cost, Quality, and Outcomes (CQO) Movement will provide training and education to help supply chain professionals make the correlation…
Advisory
The FDA UDI ruling has finally arrived - the proposed rule has published.
Letter/Comment
Recent Guidance on Meaningful Use of EHRs Makes Compliance More Difficult.
Advisory
The final regulations that provide guidance on the excise tax imposed on the sale of certain medical devices, enacted by the Health Care and Educ
As a Leading Practice, the AHRMM Board of Directors adopts that Supply Chain Services be fully integrated into high cost clinical services…